UK markets closed

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
321.21+15.75 (+5.16%)
At close: 04:04PM EDT
323.18 +1.97 (+0.61%)
After hours: 04:46PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
2,880,900
2,831,600
2,146,900
1,839,900
1,717,400
Cost of revenue
1,692,400
1,655,800
1,379,100
1,234,200
1,172,000
Gross profit
1,188,500
1,175,800
767,800
605,700
545,400
Operating expenses
Research development
55,200
52,800
46,900
38,900
40,300
Selling general and administrative
366,000
362,800
302,000
272,700
262,900
Total operating expenses
421,200
415,600
348,900
306,900
303,200
Operating income or loss
767,300
760,200
418,900
298,800
242,200
Interest expense
8,500
8,200
8,200
8,500
8,400
Total other income/expenses net
1,800
-4,100
-10,800
-2,300
4,800
Income before tax
761,800
748,900
401,300
291,800
240,700
Income tax expense
99,700
107,200
72,500
59,000
41,400
Income from continuing operations
684,400
661,800
346,200
241,700
206,900
Net income
684,400
661,800
346,200
241,700
206,900
Net income available to common shareholders
684,400
661,800
346,200
241,700
206,900
Basic EPS
-
8.89
4.68
3.27
2.80
Diluted EPS
-
8.67
4.57
3.21
2.74
Basic average shares
-
74,400
73,900
74,000
73,900
Diluted average shares
-
76,300
75,800
75,400
75,400
EBITDA
-
879,400
518,600
403,700
353,500